Uswm Ct, Llc
Clinical trials sponsored by Uswm Ct, Llc, explained in plain language.
-
Last-Chance cancer therapy offered when standard product fails specs
Disease control AVAILABLEThis program provides controlled access to a special version of a cell therapy (afami-cel) for patients with synovial sarcoma or myxoid liposarcoma when the standard manufactured product does not meet quality specifications. It is for patients who have already been prescribed thi…
Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for kids with tough cancers: trial tests 'Living Drug'
Disease control Recruiting nowThis study is testing a new personalized cell therapy called afamitresgene autoleucel in children and young adults with advanced cancers like sarcoma and neuroblastoma. The main goals are to see if the treatment is safe and if it can shrink tumors. Researchers will enroll up to 2…
Phase: PHASE1, PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
15-Year watch begins for cancer cell therapy patients
Knowledge-focused Recruiting nowThis study aims to monitor the long-term safety of people who have already received a specific type of cell therapy for cancer. It will follow up to 250 participants for 15 years after their last treatment to check for any delayed side effects. This is an observational study, mea…
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC